61 research outputs found
TUMOR MARKERS IN BONE MARROW IN PATIENTS WITH PROSTATIC CANCER
We compared prostatic specific acid phosphatase (PAP), prostatic specific
antigen (PA) and γ-seminoprotein (γ-SM) levels between bone marrow and serum for the purpose of assessing of the usefulness of these tumor markers in early detection of
bone metastasis in cases with prostatic cancer. Thirty-three patients were entered into this study. Of the patients, 20 had prostatic cancer including 11 with bone metastasis, and 13 patients had benign prostatic hypertrophy (BPH) served as controls. It seemed unlikely that bone marrow PAP, PA and γ-SM are more useful than their serum levels for detection of bone metastasis of prostatic cancer. Because correlation between bone marrow and serum levels of each marker was observed not only in cases with prostate cancer accompanied
by bone metastasis but also in metastasis-free prostatic cancer and BPH cases, it seems likely that PAP, PA and γ-SM in bone marrow circulate from peripheral blood rather than from bone metastasis of prostatic cancer
Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients
Chronic hepatitis B (CHB) leads to cirrhosis and hepatocellular carcinoma (HCC). With a cohort of 1,206 CHB patients who visited Okayama University Hospital and related hospitals in 2011 and 2012, we compared the incidence rates of HCC among the patients grouped by age, hepatitis B virus (HBV) DNA, hepatitis B e antigen (HBeAg), and treatment. HCCs were observed in 115 patients with the median observation period of 1,687 days. Among the HCC patients aged ≥ 35 years, HBV DNA ≥ 4 log copies/mL and positive HBeAg at diagnosis (n=184), the HCC incidence rate was 8.4% at 5 years in the entecavir (ETV)-treated patients, 21.8% in the lamivudine (LVD)-treated patients, and 26.4% among the patients not treated with drugs. The cumulative HCC incidence was significantly reduced in the ETV-treated patients compared to those treated with LVD or not treated (p=0.013). Among the patients aged ≥ 35 years with HBV DNA ≥ 4 log copies/mL and negative HBeAg (n=237), the cumulative HCC incidence was 14.6% in 5 years in ETV group and 13.9% among those not treated with a drug (p>0.05). Only small numbers of HCCs occurred in other patients. In CHB patients aged≥35 years with HBV DNA ≥4 log copies/mL and positive HBeAg, ETV treatment is recommended for the suppression of HCC development
Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy
Daclatasvir (DCV) + asunaprevir (ASV) combination therapy has become available for patients with hepatitis C virus (HCV) serogroup 1 infection. We studied the efficacy of this therapy by focusing on the factors associated with sustained virological responses (SVR) including resistance-associated variants (RAVs) and mixed infection of different HCV genotypes. We enrolled 951 HCV serogroup 1-positive patients who received this combination therapy at our hospital or affiliated hospitals. The presence of RAVs in non-structural (NS) regions 3 and 5A was analyzed by direct sequencing. HCV genotypes were determined by PCR with genotype-specific primers targeting HCV core and NS5B regions. SVR was achieved in 91.1% of patients. Female sex, age > 70 years, and RAVs were significantly associated with non-SVR (p<0.01 for all). Propensity score-matching results among the patients without RAVs regarding sex, age, and fibrosis revealed that mixed HCV infection determined by HCV NS5B genotyping showed significantly lower SVR rates than 1B-mono infection (p=0.02). Female sex and RAVs were significant factors associated with treatment failure of this combination therapy for patients with HCV serogroup 1 infection. Mixed HCV infection other than 1B-mono infection would be useful for predicting treatment failure
The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
Steroids are often administered at the time of transcatheter arterial chemoembolization (TACE), a standard treatment of hepatocellular carcinoma (HCC), with the expectation of preventing postembolization syndrome. Here we investigated the precise effects of steroids on TACE. We prospectively enrolled 144 HCC patients from 10 hospitals who underwent TACE. Three hospitals used steroids (steroid group, n=77) and the rest did not routinely use steroids (control group, n=67). The occurrence of adverse events and the algetic degree at 1-5 days post-treatment were compared between the groups. Fever (grades 0-2) after TACE was significantly less in the steroid group (56/21/0) compared to the control group (35/29/3, p=0.005, Cochran-Armitage test for trend). The suppressive effect of steroids against fever was prominent in females (p=0.001). Vomiting (G0/G1/ G2-) was also less frequent in the steroid group (70/5/2) versus the control group (53/10/3), but not significantly (p=0.106). The algetic degree and the grade of hematological adverse events, including hyperglycemia, did not differ between the groups. We conclude that the administration of steroids was useful for the prevention of adverse events after TACE in patients with HCC
EMPRESS. XII. Statistics on the Dynamics and Gas Mass Fraction of Extremely-Metal Poor Galaxies
We present demography of the dynamics and gas-mass fraction of 33 extremely
metal-poor galaxies (EMPGs) with metallicities of and low
stellar masses of in the local universe. We conduct deep
optical integral-field spectroscopy (IFS) for the low-mass EMPGs with the
medium high resolution () grism of the 8m-Subaru FOCAS IFU instrument
by the EMPRESS 3D survey, and investigate H emission of the EMPGs.
Exploiting the resolution high enough for the low-mass galaxies, we derive gas
dynamics with the H lines by the fitting of 3-dimensional disk models.
We obtain an average maximum rotation velocity () of
and an average intrinsic velocity dispersion
() of for 15 spatially resolved EMPGs
out of the 33 EMPGs, and find that all of the 15 EMPGs have
suggesting dispersion dominated systems. There is a
clear decreasing trend of with the decreasing stellar
mass and metallicity. We derive the gas mass fraction () for
all of the 33 EMPGs, and find no clear dependence on stellar mass and
metallicity. These and trends should
be compared with young high- galaxies observed by the forthcoming JWST IFS
programs to understand the physical origins of the EMPGs in the local universe.Comment: 18 pages, 9 figures, accepted for publication in Ap
EMPRESS. IX. Extremely Metal-Poor Galaxies are Very Gas-Rich Dispersion-Dominated Systems: Will JWST Witness Gaseous Turbulent High-z Primordial Galaxies?
We present kinematics of 6 local extremely metal-poor galaxies (EMPGs) with
low metallicities () and low stellar masses
(). Taking deep medium-high resolution
() integral-field spectra with 8.2-m Subaru, we resolve the small
inner velocity gradients and dispersions of the EMPGs with H emission.
Carefully masking out sub-structures originated by inflow and/or outflow, we
fit 3-dimensional disk models to the observed H flux, velocity, and
velocity-dispersion maps. All the EMPGs show rotational velocities () of 5--23 km s smaller than the velocity dispersions
() of 17--31 km s, indicating dispersion-dominated () systems affected by inflow and/or outflow. Except
for two EMPGs with large uncertainties, we find that the EMPGs have very large
gas-mass fractions of . Comparing our results with
other H kinematics studies, we find that
decreases and increases with decreasing metallicity, decreasing
stellar mass, and increasing specific star-formation rate. We also find that
simulated high- () forming galaxies have gas fractions and dynamics
similar to the observed EMPGs. Our EMPG observations and the simulations
suggest that primordial galaxies are gas-rich dispersion-dominated systems,
which would be identified by the forthcoming James Webb Space Telescope (JWST)
observations at .Comment: Submitted to ApJ; After revisio
The Hyper Suprime-Cam SSP survey: Overview and survey design
Hyper Suprime-Cam (HSC) is a wide-field imaging camera on the prime focus of the 8.2-m Subaru telescope on the summit of Mauna Kea in Hawaii. A team of scientists from Japan, Taiwan, and Princeton University is using HSC to carry out a 300-night multi-band imaging survey of the high-latitude sky. The survey includes three layers: the Wide layer will cover 1400 deg2 in five broad bands (grizy), with a 5 σ point-source depth of r ≈ 26. The Deep layer covers a total of 26 deg2 in four fields, going roughly a magnitude fainter, while the UltraDeep layer goes almost a magnitude fainter still in two pointings of HSC (a total of 3.5 deg2). Here we describe the instrument, the science goals of the survey, and the survey strategy and data processing. This paper serves as an introduction to a special issue of the Publications of the Astronomical Society of Japan, which includes a large number of technical and scientific papers describing results from the early phases of this survey
- …